Version 5.4
Homo sapiens Gene: WFDC10A
Summary
InnateDB Gene IDBG-77899.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol WFDC10A
Gene Name WAP four-disulfide core domain 10A
Synonyms
Species Homo sapiens
Ensembl Gene ENSG00000180305
Encoded Proteins
IDBP-77901
WAP four-disulfide core domain 10A
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the telomeric cluster. [provided by RefSeq, Jul 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 20:45629526-45631196
Strand Forward strand
Band q13.12
Transcripts
ENST00000372643 ENSP00000361726
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0004867 serine-type endopeptidase inhibitor activity
GO:0030414 peptidase inhibitor activity
Biological Process
GO:0010951 negative regulation of endopeptidase activity
Cellular Component
GO:0005576 extracellular region
Orthologs
No orthologs found for this gene
Cross-References
SwissProt Q9H1F0
TrEMBL
UniProt Splice Variant
Entrez Gene 140832
UniGene
RefSeq NM_080753
HUGO HGNC:16139
OMIM
CCDS CCDS13363
HPRD
IMGT
EMBL AL031671 AY038182 BC131579 CH471077
GenPept AAI31580 AAK72469 CAI22433 EAW75827
RNA Seq Atlas 140832

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca